Medications

FDA panel backs long-acting Boehringer inhaler

(AP)—A panel of federal health experts is overwhelmingly recommending approval for a long-acting inhaler to treat people suffering from chronic lung disease.

Diseases, Conditions, Syndromes

Severity of emphysema predicts mortality

Severity of emphysema, as measured by computed tomography (CT), is a strong independent predictor of all-cause, cardiovascular, and respiratory mortality in ever-smokers with or without chronic obstructive pulmonary disease ...

Health

More Americans have at least 2 chronic health issues: CDC

(HealthDay) -- The number of Americans aged 45 and older with two or more chronic conditions has grown over the past decade, new research estimates, with seniors especially vulnerable to a rising risk of both diabetes and ...

Diseases, Conditions, Syndromes

Tudorza pressair approved for COPD

(HealthDay) -- The Tudorza Pressair (aclidinium bromide) inhaler has been approved by the U.S. Food and Drug Administration to treat narrowing of the lung airways associated with chronic obstructive pulmonary disease (COPD) ...

page 6 from 8